Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
三氟尿苷/替吡嘧啶联合贝伐单抗与三氟尿苷/替吡嘧啶或瑞戈非尼治疗转移性结直肠癌的临床疗效:一项多中心队列研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106907
Moik, F; Huemer, F; Doleschal, B; Taghizadeh, H; Reimann, P; Kostmann, S M; Wagner, L; Abdel Hamid, M; Zimmer, K C; Suppé, S A; Bachleitner, C; Schaberl-Moser, R; Amann, A; Wolf, D; Greil, R; Jost, P J; Winder, T; Rumpold, H; Weiss, L; Gerger, A; Seeber, A; Riedl, J M